Vivosim Labs Inc 's ROA from the first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Vivosim Labs Inc 's ROA in the first quarter of 2026?
Vivosim Labs Inc recorded a cumulative net loss of $-12 million during 12 months ending in the first quarter of 2026, resulting in a negative return on assets (ROA) of -144.92%.

However, within the Healthcare sector 879 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the fourth quarter of 2026 from 3514 to 3732.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) I. Quarter	(Mar 31 2026) IV. Quarter	(Dec 31 2025) III. Quarter	(Sep 30 2025) II. Quarter	(Jun 30 2025) I. Quarter
Y / Y Total Assets Change	-68.05 %	-60.42 %	129.17 %	56.43 %	35.55 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-12	-14	-1	-2	-2
Return On Assets (TTM)	-144.92 %	-131.06 %	-9.62 %	-18.52 %	-20.24 %
VIVS's Total Ranking	# 3732	# 3514	# 3581	# 3784	# 5442
Total Assets (TTM) in million	4	6	15	10	12
Seq. Total Assets Change	-33.2 %	-60.42 %	46.98 %	-17.8 %	-17.24 %
Seq. Net Income Change	-	-	-	-	-

VIVS's 5 Years Annual ROA >> Back to VIVS Management Effectiveness >> Compare VIVS ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 139
Sector	# 880
Overall	# 5014

Return On Assets Statistics
High	Average	Low
62.58 %	-100.2 %	-1399.27 %
(Jun 30 2013)		(Jun 30 2012)

Financial Statements
Vivosim Labs Inc 's Assets	$ 4 million	VIVS's Balance sheet
Vivosim Labs Inc 's Income	$ -1 million	Quarterly VIVS's Income Statement
VIVS's Income by Division		See VIVS's Income by Division

Annual Return On Assets	(Mar 31 2026) FY 2026	(Mar 31 2025) FY 2025	(Mar 31 2024) FY 2024	(Mar 31 2023) FY 2023	(Mar 31 2022) FY 2022
Y / Y Total Assets Change	-40.3 %	129.17 %	-68.18 %	-38.03 %	-19.07 %
Total Assets in million	9	15	6	20	32
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-14	-2	-15	-17	-11
Annual Return On Assets	-159.35 %	-17.1 %	-231.08 %	-86.51 %	-35.56 %

VIVS's 5 Years Annual ROA >> Back to VIVS Management Effectiveness >> Compare VIVS ROA to its Competitors

More Return On Assets Ratios
VIVS's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
VIVS's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for VIVS's Competitors
Subscribers only: Roa for Vivosim Labs Inc 's Suppliers
Subscribers only: Return On Assets for VIVS's Customers

You may also want to know
VIVS's Roi	VIVS's Inventory Turnover Ratio	VIVS's Growth Rates	VIVS's Dividend Comparisons
	VIVS's Profitability Ratios	VIVS's Asset Turnover Ratio	VIVS's Dividend Growth
VIVS's Roe	VIVS's Valuation Ratios	VIVS's Financial Strength Ratios	VIVS's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-26T06:52:06+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.